1 | 124I-AT03 | - | - | - | - | [1] 28 28 |
2 | 124I-labeled monoclonal antibody Mu 11-1F4 | - | - | - | - | [1] 28 28 |
3 | 124I-p5+14 Injection | - | - | - | - | [1] 28 28 |
4 | 1H-Pyrazol | [1] Pyrazole Pyrazole | - | - | - | [5] 2 2, 28, 46, 75, 154 |
5 | 2',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid | - | - | - | - | [1] 28 28 |
6 | 2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylat | - | - | - | - | [1] 28 28 |
7 | 2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate | - | - | - | - | [1] 28 28 |
8 | 26866138 | - | - | - | - | [1] 28 28 |
9 | 3-(3-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)PROPOXY)-4-FLUOROBENZOIC ACID | [1] Pyrazole Pyrazole | - | - | - | [1] 28 28 |
10 | 4'-iodo-4'-deoxydoxorubicin | [1] Iodine Iodine | [1] D00108
D00108
| - | - | [1] 28 28 |
11 | [18F]Florbetaben | - | - | - | - | [1] 28 28 |
12 | A01AC02 | - | - | - | - | [1] 28 28 |
13 | Aciclin | - | - | - | - | [1] 28 28 |
14 | Aciclovir | [1] Acyclovir Acyclovir | [1] D00222
D00222
| - | - | [3] 13 13, 28, 60 |
15 | Acoramidis | - | - | - | - | [1] 28 28 |
16 | Acyclovir | [1] Acyclovir Acyclovir | [1] D00222
D00222
| - | - | [2] 13 13, 28 |
17 | AG10 | - | - | - | - | [1] 28 28 |
18 | AG10 HCl | - | - | - | - | [1] 28 28 |
19 | AL | - | - | - | - | [11] 5 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127 |
20 | ALKERAN | [1] Melphalan Melphalan | [1] D00369
D00369
| - | - | [2] 28 28, 60 |
21 | ALN-51547 | - | - | - | - | [1] 28 28 |
22 | ALN-TTRSC | - | - | - | - | [1] 28 28 |
23 | Amifostine | [1] Amifostine Amifostine | [1] D00226
D00226
| - | - | [1] 28 28 |
24 | Amifostine trihydrate | [1] Amifostine Amifostine | [1] D00226
D00226
| - | - | [1] 28 28 |
25 | Amiodarone | [1] Amiodarone Amiodarone | [1] D02910
D02910
| [16] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [32] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 28 28, 127 |
26 | Anakinra | [1] Anakinra Anakinra | [1] D02934
D02934
| [2] IL1R1 IL1R1, IL1R2 💬 | [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [16] 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 |
27 | Aprotinin | [1] Aprotinin Aprotinin | [1] D02971
D02971
| - | - | [1] 28 28 |
28 | BD | - | - | - | - | [2] 28 28, 56 |
29 | Belantamab mafodotin | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
30 | Belantamab mafodotin 1.9 mg/kg (8 weeks) | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
31 | Belantamab mafodotin 1.9mg/kg or 2.5mg/kg every 4 weeks, 6 weeks or 8 weeks as determined by Part 1 recommended dosages | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
32 | Belantamab mafodotin 2.5 mg/kg (4 weeks) | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
33 | Belantamab mafodotin 2.5 mg/kg (6 weeks) | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
34 | Belantamab mafodotin 2.5 mg/kg (8 weeks) | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
35 | Bendamustine | [1] Bendamustine Bendamustine | [1] D07501
D07501
| - | - | [2] 28 28, 61 |
36 | Betamethasone | [1] Betamethasone Betamethasone | [1] D00244
D00244
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [8] 2 2, 28, 46, 65, 83, 90, 96, 235 |
37 | BIRTAMIMAB | [1] Birtamimab Birtamimab | [1] D11373
D11373
| - | - | [1] 28 28 |
38 | BMDex | - | - | - | - | [1] 28 28 |
39 | BORTEZOMIB | [1] Bortezomib Bortezomib | [1] D03150
D03150
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [17] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 |
40 | Bortezomib Accord | [1] Bortezomib Bortezomib | [1] D03150
D03150
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 |
41 | Bortezomib D-mannitol | [2] Bortezomib Bortezomib, Mannitol | [2] D00062
D00062
,
D03150
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 |
42 | Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone | [2] Bortezomib Bortezomib, Dexamethasone | [2] D00292
D00292
,
D03150
| [2] NR3C1 NR3C1, PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 |
43 | Busulfan | [1] Busulfan Busulfan | [1] D00248
D00248
| - | - | [13] 19 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 |
44 | CAEL-101 | - | - | - | - | [1] 28 28 |
45 | Carboplatin | [1] Carboplatin Carboplatin | [1] D01363
D01363
| - | - | [4] 28 28, 34, 60, 85 |
46 | Carfilzomib | [1] Carfilzomib Carfilzomib | [1] D08880
D08880
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 |
47 | Carmustine | [1] Carmustine Carmustine | [1] D00254
D00254
| - | - | [5] 11 11, 13, 14, 28, 60 |
48 | CC | - | - | - | - | [13] 28 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271 |
49 | CC-4047 | - | - | - | - | [2] 28 28, 51 |
50 | CC-5013 | - | - | - | - | [2] 28 28, 96 |
51 | Cetirizina | [1] Cetirizine Cetirizine | [1] D07662
D07662
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 28, 300 |
52 | CETIRIZINA DICLORIDRATO | [1] Cetirizine Cetirizine | [1] D07662
D07662
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
53 | Ch11-1F4 (NSC-711516) | - | - | - | - | [1] 28 28 |
54 | Chemotherapy | - | - | - | - | [3] 28 28, 60, 285 |
55 | CHIMERIC FIBRIL-REACTIVE IGG1K MONOCLONAL ANTIBODY 11-1F4 | - | - | - | - | [1] 28 28 |
56 | Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4 | - | - | - | - | [1] 28 28 |
57 | CHX A-DTPA anti-CD66 antibody | [1] Pentetic acid Pentetic acid | [1] D05422
D05422
| - | - | [1] 28 28 |
58 | CHX-A-DTPA-Anti-CD66 | [1] Pentetic acid Pentetic acid | [1] D05422
D05422
| - | - | [1] 28 28 |
59 | Cisplatin | [1] Cisplatin Cisplatin | [1] D00275
D00275
| - | - | [1] 28 28 |
60 | CPHC (carboxy pyrrolidine hexanoyl pyrrolidone carboxylate) | [1] Pyrrolidine Pyrrolidine | - | - | - | [1] 28 28 |
61 | Current treatment of AL-CM | - | - | - | - | [1] 28 28 |
62 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
63 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [4] D00287
D00287
,
D00292
,
D03150
,
D07760
| [2] NR3C1 NR3C1, PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 |
64 | Cyclophosphamide, Bortezomib, dexamethasone | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [4] D00287
D00287
,
D00292
,
D03150
,
D07760
| [2] NR3C1 NR3C1, PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 |
65 | Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab | [4] Bortezomib Bortezomib, Cyclophosphamide, Daratumumab, Dexamethasone | [5] D00287
D00287
,
D00292
,
D03150
,
D07760
,
D10777
| [3] CD38 CD38, NR3C1, PSMB5 💬 | [16] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | [1] 28 28 |
66 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 |
67 | D-glucitol | [1] Sorbitol Sorbitol | [1] D00096
D00096
| - | - | [2] 28 28, 299 |
68 | D-glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1) | [1] Sorbitol Sorbitol | [1] D00096
D00096
| - | - | [1] 28 28 |
69 | D-glucitol, 1-deoxy-1-(methylamino)-,2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1) | [1] Sorbitol Sorbitol | [1] D00096
D00096
| - | - | [1] 28 28 |
70 | Daratumumab | [1] Daratumumab Daratumumab | [1] D10777
D10777
| [1] CD38 CD38 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [5] 13 13, 28, 48, 49, 63 |
71 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) | [2] Daratumumab Daratumumab, Hyaluronidase (human recombinant) | [1] D10777
D10777
| [1] CD38 CD38 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 |
72 | Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20) | [1] Daratumumab Daratumumab | [1] D10777
D10777
| [1] CD38 CD38 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 |
73 | Daratumumab Injection | [1] Daratumumab Daratumumab | [1] D10777
D10777
| [1] CD38 CD38 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [3] 28 28, 49, 63 |
74 | Darzalex | [1] Daratumumab Daratumumab | [1] D10777
D10777
| [1] CD38 CD38 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [3] 28 28, 49, 63 |
75 | DAZARLEX | - | - | - | - | [1] 28 28 |
76 | Deaxamethasone | - | - | - | - | [1] 28 28 |
77 | Decadron | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
78 | DESAMETASONE | - | - | - | - | [1] 28 28 |
79 | Dexametasone | - | - | - | - | [1] 28 28 |
80 | Dexamethason | - | - | - | - | [4] 13 13, 28, 46, 331 |
81 | Dexamethasone | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [22] 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
82 | Dexamethasone 4 mg JENAPHARM | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
83 | Dexamethasone Oral, 10 mg | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
84 | Dexamethasone Oral, 20 mg | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
85 | DEXAMETHASONE SODIUM SULFATE | [3] Dexamethasone Dexamethasone, Sodium sulfate, Sulfate ion | [2] D00292
D00292
,
D05877
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
86 | Dexamethasone, 40 mg | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
87 | Dexaton | - | - | - | - | [1] 28 28 |
88 | Dezamizumab | [1] Dezamizumab Dezamizumab | [1] D11471
D11471
| [1] APCS APCS 💬 | - | [1] 28 28 |
89 | Diflunisal | [1] Diflunisal Diflunisal | [1] D00130
D00130
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 28 28 |
90 | Diflunisal (dolobid) | [1] Diflunisal Diflunisal | [1] D00130
D00130
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 28 28 |
91 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias) | [1] Amiodarone Amiodarone | [1] D02910
D02910
| [16] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [32] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 28 28 |
92 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus EGCG | [2] Amiodarone Amiodarone, Epigallocatechin gallate | [1] D02910
D02910
| [16] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [32] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 28 28 |
93 | Dolobid | - | - | - | - | [1] 28 28 |
94 | Donor lymphocytes | - | - | - | - | [1] 28 28 |
95 | Doxorubicin | [1] Doxorubicin Doxorubicin | [1] D03899
D03899
| [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [5] 26 26, 28, 34, 65, 331 |
96 | Doxycycline | [1] Doxycycline Doxycycline | [2] D00307
D00307
,
D07876
| - | - | [17] 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
97 | DoxyHEXAL® tabs 100 mg Tabletten | - | - | - | - | [1] 28 28 |
98 | DTPA | [1] Pentetic acid Pentetic acid | [1] D05422
D05422
| - | - | [2] 28 28, 299 |
99 | EGCG | [1] Epigallocatechin gallate Epigallocatechin gallate | - | - | - | [9] 6 6, 8, 13, 17, 28, 85, 113, 206, 299 |
100 | Elotuzumab | [1] Elotuzumab Elotuzumab | [1] D09337
D09337
| [1] SLAMF7 SLAMF7 💬 | - | [1] 28 28 |
101 | Enbrel | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [6] 28 28, 46, 60, 107, 271, 285 |
102 | ENDOXAN | - | - | - | - | [7] 13 13, 28, 43, 44, 85, 96, 222 |
103 | Epigallocatechin | [1] Epigallocatechin Epigallocatechin | - | - | - | [5] 8 8, 13, 28, 85, 113 |
104 | Epigallocatechin-3-gallate | [2] Epigallocatechin Epigallocatechin, Epigallocatechin gallate | - | - | - | [3] 8 8, 28, 85 |
105 | Epigallocatechin-3-gallate (EGCG) | [2] Epigallocatechin Epigallocatechin, Epigallocatechin gallate | - | - | - | [2] 28 28, 85 |
106 | Eplontersen | [1] AKCEA-TTR-LRx AKCEA-TTR-LRx | - | - | - | [1] 28 28 |
107 | Etoposide | [1] Etoposide Etoposide | [1] D00125
D00125
| [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [11] 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
108 | Filgrastim | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [28] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
109 | Fludarabine | [1] Fludarabine Fludarabine | [1] D07966
D07966
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [19] 11 11, 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
110 | Fludarabine phosphate | [2] Fludarabine Fludarabine, Phosphate ion | [1] D07966
D07966
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [12] 28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 |
111 | FORTECORTIN | - | - | - | - | [2] 28 28, 65 |
112 | Fx-1006A | [1] Fx-1006A Fx-1006A | - | - | - | [1] 28 28 |
113 | Gelatin | [1] Gelatin Gelatin | [2] D00115
D00115
,
D06892
| - | - | [5] 28 28, 62, 78, 97, 269 |
114 | Granulocyte Colony Stimulating Factor | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [6] 2 2, 28, 36, 57, 65, 85 |
115 | Green Tea | [1] Green tea leaf Green tea leaf | [1] D06903
D06903
| - | - | [4] 6 6, 17, 28, 46 |
116 | Green Tea Extract | [1] Green tea leaf Green tea leaf | [1] D06903
D06903
| - | - | [1] 28 28 |
117 | GSK2315698 | - | - | - | - | [1] 28 28 |
118 | GSK2398852 | - | - | - | - | [1] 28 28 |
119 | GSK2857916 | - | - | - | - | [1] 28 28 |
120 | GSK3039294 | - | - | - | - | [1] 28 28 |
121 | H02AB02 | - | - | - | - | [1] 28 28 |
122 | H02AB02 Desametasone | - | - | - | - | [1] 28 28 |
123 | Human Transthyretin Antisense Oligonucleotide | - | - | - | - | [1] 28 28 |
124 | Humanized IgG1 kappa antiamyloid | - | - | - | - | [1] 28 28 |
125 | Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody | - | - | - | - | [1] 28 28 |
126 | HUMAX-CD38 | - | - | - | - | [2] 28 28, 63 |
127 | HuMax-CD38, 3003-005 | - | - | - | - | [1] 28 28 |
128 | Hyaluronidase | [1] Hyaluronidase Hyaluronidase | [3] D04455
D04455
,
D04456
,
D06604
| - | - | [5] 14 14, 28, 51, 65, 331 |
129 | I124-AT01 only | - | - | - | - | [1] 28 28 |
130 | Ibrutinib | [1] Ibrutinib Ibrutinib | [1] D10223
D10223
| [1] BTK BTK 💬 | [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [3] 28 28, 60, 61 |
131 | Imatinib | [1] Imatinib Imatinib | [1] D08066
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [12] 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 |
132 | Imatinib Mesylate | [1] Imatinib Imatinib | [1] D08066
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [5] 13 13, 28, 34, 51, 86 |
133 | Imnovid | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 28 28, 51 |
134 | Indium | [1] Indium Indium | - | - | - | [3] 28 28, 84, 299 |
135 | Indium 111-radiolabelled anti-CD66 | [1] Indium Indium | - | - | - | [1] 28 28 |
136 | Indium 111 labelled Anti-CD66 | [1] Indium Indium | - | - | - | [1] 28 28 |
137 | Inoserten | - | - | - | - | [1] 28 28 |
138 | INOTERSEN | [1] Inotersen Inotersen | [1] D10940
D10940
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
139 | Interferon alfa | [1] Interferon alfa Interferon alfa | [1] D03305
D03305
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [5] 25 25, 26, 28, 56, 96 |
140 | Iodo | [1] Iodine Iodine | [1] D00108
D00108
| - | - | [1] 28 28 |
141 | ION-682884 | - | - | - | - | [1] 28 28 |
142 | IONIS-TTR Rx | - | - | - | - | [1] 28 28 |
143 | Isatuximab | [1] Isatuximab Isatuximab | [1] D11050
D11050
| [1] CD38 CD38 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [3] 28 28, 61, 283 |
144 | ISIS 420915 | - | - | - | - | [1] 28 28 |
145 | Isis 420915/GSK 299872 | - | - | - | - | [1] 28 28 |
146 | Ixazomib | [1] Ixazomib Ixazomib | [1] D10130
D10130
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [4] 13 13, 16, 28, 51 |
147 | JnJ 54767414 | - | - | - | - | [1] 28 28 |
148 | JNJ-54767414 | - | - | - | - | [2] 28 28, 49 |
149 | Kineret | [1] Anakinra Anakinra | [1] D02934
D02934
| [2] IL1R1 IL1R1, IL1R2 💬 | [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [9] 28 28, 41, 46, 49, 65, 106, 107, 266, 299 |
150 | KINERET*SC 7SIR 100MG 0,67ML | [1] Anakinra Anakinra | [1] D02934
D02934
| [2] IL1R1 IL1R1, IL1R2 💬 | [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [3] 28 28, 46, 107 |
151 | L01AA03 | - | - | - | - | [1] 28 28 |
152 | Lenalidomide | [1] Lenalidomide Lenalidomide | [1] D04687
D04687
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8] 16 16, 26, 28, 34, 49, 284, 300, 331 |
153 | Lenalidomide 25mg | [1] Lenalidomide Lenalidomide | [1] D04687
D04687
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 |
154 | Lenalidomide, Dexamethasone and Cyclophosphamide | [3] Cyclophosphamide Cyclophosphamide, Dexamethasone, Lenalidomide | [4] D00287
D00287
,
D00292
,
D04687
,
D07760
| [2] NR3C1 NR3C1, TNF 💬 | [68] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 |
155 | Lenogastrim | - | - | - | - | [1] 28 28 |
156 | Mannitol | [1] Mannitol Mannitol | [1] D00062
D00062
| - | - | [7] 6 6, 13, 28, 60, 96, 113, 299 |
157 | Meglumine | [1] Meglumine Meglumine | [1] D01796
D01796
| - | - | [1] 28 28 |
158 | MELFLUFEN | [1] Melphalan flufenamide Melphalan flufenamide | [1] D11865
D11865
| - | - | [1] 28 28 |
159 | Melphalan | [1] Melphalan Melphalan | [1] D00369
D00369
| - | - | [15] 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 |
160 | Melphalan fulfenamide hydrochloride | [1] Melphalan Melphalan | [1] D00369
D00369
| - | - | [1] 28 28 |
161 | Melphalan, thalidomide and dexamethasone | [3] Dexamethasone Dexamethasone, Melphalan, Thalidomide | [3] D00292
D00292
,
D00369
,
D00754
| [2] NR3C1 NR3C1, TNF 💬 | [68] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 |
162 | Melphalan-Flufenamide (Melflufen) | [2] Melphalan Melphalan, Melphalan flufenamide | [2] D00369
D00369
,
D11865
| - | - | [1] 28 28 |
163 | Microarray analysis | - | - | - | - | [2] 28 28, 285 |
164 | Miridesap | [1] Miridesap Miridesap | [1] D11464
D11464
| [1] APCS APCS 💬 | - | [1] 28 28 |
165 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
166 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] D00752
D00752
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
167 | N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium | - | - | - | - | [1] 28 28 |
168 | NEOD001 | - | - | - | - | [1] 28 28 |
169 | NEUPOGEN | - | - | - | - | [4] 13 13, 28, 51, 285 |
170 | NTLA-2001 | - | - | - | - | [1] 28 28 |
171 | Null | - | - | - | - | [16] 6 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 |
172 | Oral drops solution | - | - | - | - | [1] 28 28 |
173 | PARACETAMOLO | - | - | - | - | [9] 2 2, 11, 14, 19, 28, 53, 61, 63, 300 |
174 | Paracetamolo Zentiva Italia | - | - | - | - | [1] 28 28 |
175 | PEGYLATED RECOMBINANT HUMAN HYALURONIDASE PH20 | [2] Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3] D04455
D04455
,
D04456
,
D06604
| - | - | [1] 28 28 |
176 | PF-06291826-83/Fx-1006A | [1] Fx-1006A Fx-1006A | - | - | - | [1] 28 28 |
177 | Phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [32] 2 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
178 | Pomalidomide | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [5] 28 28, 51, 85, 227, 331 |
179 | Pomalidomide and Dexamethasone | [2] Dexamethasone Dexamethasone, Pomalidomide | [2] D00292
D00292
,
D08976
| [3] IL6 IL6, NR3C1, TNF 💬 | [81] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 |
180 | Psyllium | [1] Plantago seed Plantago seed | [1] D05525
D05525
| - | - | [3] 6 6, 28, 97 |
181 | Pyrrolidine | [1] Pyrrolidine Pyrrolidine | - | - | - | [2] 28 28, 97 |
182 | Recombinant human hyaluronidase | [2] Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3] D04455
D04455
,
D04456
,
D06604
| - | - | [3] 14 14, 28, 65 |
183 | Recombinant human hyaluronidase PH20 | [2] Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3] D04455
D04455
,
D04456
,
D06604
| - | - | [1] 28 28 |
184 | Recombinant interferon alfa | [1] Interferon alfa Interferon alfa | [1] D03305
D03305
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2] 26 26, 28 |
185 | REVLIMID | [1] Lenalidomide Lenalidomide | [1] D04687
D04687
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 |
186 | Revusiran | [1] Revusiran Revusiran | - | - | - | [1] 28 28 |
187 | Sargramostim | [1] Sargramostim Sargramostim | [1] D05803
D05803
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [7] 6 6, 28, 60, 62, 96, 229, 285 |
188 | Selinexor | [1] Selinexor Selinexor | [1] D11222
D11222
| [1] XPO1 XPO1 💬 | [5] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Nucleocytoplasmic transport, Ribosome biogenesis in eukaryotes, Viral life cycle - HIV-1 💬 | [1] 28 28 |
189 | Siltuximab | [1] Siltuximab Siltuximab | [1] D09669
D09669
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [2] 28 28, 331 |
190 | Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg) | - | - | - | - | [1] 28 28 |
191 | SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [4] D00287
D00287
,
D00292
,
D03150
,
D07760
| [2] NR3C1 NR3C1, PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 |
192 | Sodium sulfate | [2] Sodium sulfate Sodium sulfate, Sulfate ion | [1] D05877
D05877
| - | - | [1] 28 28 |
193 | SOM0226 | - | - | - | - | [1] 28 28 |
194 | Standard of Care Chemotherapy | - | - | - | - | [1] 28 28 |
195 | Standard of care therapy | - | - | - | - | [1] 28 28 |
196 | STI-6129 | - | - | - | - | [1] 28 28 |
197 | Sulfate | [1] Sulfate ion Sulfate ion | - | - | - | [27] 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 |
198 | Sunitinib | [1] Sunitinib Sunitinib | [1] D08552
D08552
| [9] CSF1R CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 | [36] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 28 28, 34 |
199 | Sunitinib malate | [1] Sunitinib Sunitinib | [1] D08552
D08552
| [9] CSF1R CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 | [36] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 28 28 |
200 | Tafamidis | [1] Tafamidis Tafamidis | [1] D09673
D09673
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
201 | Tafamidis meglumine | [2] Meglumine Meglumine, Tafamidis | [2] D01796
D01796
,
D09673
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
202 | Tafamidis meglumine 20 mg soft gelatin capsules | [3] Gelatin Gelatin, Meglumine, Tafamidis | [4] D00115
D00115
,
D01796
,
D06892
,
D09673
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
203 | Tafamidis Meglumine 20mg Soft Gelatin Capsule (Clinical trial image) | [3] Gelatin Gelatin, Meglumine, Tafamidis | [4] D00115
D00115
,
D01796
,
D06892
,
D09673
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
204 | Tafamidis Meglumine 20mg Soft Gelatin Capsule (Commerical image) | [3] Gelatin Gelatin, Meglumine, Tafamidis | [4] D00115
D00115
,
D01796
,
D06892
,
D09673
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
205 | Tasmar | [1] Tolcapone Tolcapone | [1] D00786
D00786
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [2] 6 6, 28 |
206 | Tea Extract | [1] Green tea leaf Green tea leaf | [1] D06903
D06903
| - | - | [1] 28 28 |
207 | Thalidomide | [1] Thalidomide Thalidomide | [1] D00754
D00754
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [20] 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
208 | Thiotepa | [1] Thiotepa Thiotepa | [1] D00583
D00583
| - | - | [12] 13 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285 |
209 | TOLCAPONE | [1] Tolcapone Tolcapone | [1] D00786
D00786
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [3] 6 6, 28, 127 |
210 | Velcade | [1] Bortezomib Bortezomib | [1] D03150
D03150
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [3] 11 11, 28, 61 |
211 | VELCADE*1FL 3,5MG | [1] Bortezomib Bortezomib | [1] D03150
D03150
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 |
212 | Venetoclax | [1] Venetoclax Venetoclax | [1] D10679
D10679
| [1] BCL2 BCL2 💬 | [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | [1] 28 28 |
213 | Venetoclax MTD with Dexamethasone | [2] Dexamethasone Dexamethasone, Venetoclax | [2] D00292
D00292
,
D10679
| [2] BCL2 BCL2, NR3C1 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | [1] 28 28 |
214 | Venetoclax Oral Tablet, 200 mg | [1] Venetoclax Venetoclax | [1] D10679
D10679
| [1] BCL2 BCL2 💬 | [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | [1] 28 28 |
215 | Venetoclax Oral Tablet, 400 mg | [1] Venetoclax Venetoclax | [1] D10679
D10679
| [1] BCL2 BCL2 💬 | [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | [1] 28 28 |
216 | Vyndaqel | [1] Tafamidis Tafamidis | [1] D09673
D09673
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
217 | Vyndaqel 20mg soft capsule | [1] Tafamidis Tafamidis | [1] D09673
D09673
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
218 | Yttrium-90 | [1] Yttrium Y-90 Yttrium Y-90 | - | - | - | [1] 28 28 |
219 | Yttrium-90 radiolabelled anti-CD66 antibody | [1] Yttrium Y-90 Yttrium Y-90 | - | - | - | [1] 28 28 |
220 | Yttrium90 radiolabelled antiCD66 | [1] Yttrium Y-90 Yttrium Y-90 | - | - | - | [1] 28 28 |
221 | Zirtec | - | - | - | - | [1] 28 28 |
222 | ZN-d5 | - | - | - | - | [1] 28 28 |